Evidence map›Paper›PMID 19265433›Full record

ArticleBiochemistry2009

Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.

J Jefferson P Perry, Amy S Hearn, Diane E Cabelli, Harry S Nick, John A Tainer, David N Silverman

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. The curious life of human mitochondrial SOD2.International journal of biological macromolecules · 2026
    Review
  2. Review
  3. Article
  4. A lesson in symmetry.Nature structural & molecular biology · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Combined QM/MM and Monte Carlo study for redox leveling in Mn and Fe superoxide dismutase.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2018
    Article
  17. Review
  18. Insights into the Dichotomous Regulation of SOD2 in Cancer.Antioxidants (Basel, Switzerland) · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J Jefferson P PerryDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA. jjperry@scripps.edu
Amy S Hearn
Diane E Cabelli
Harry S Nick
John A Tainer
David N Silverman
University of Florida · US

Funding

CATALYTIC MECHANISM OF HUMAN MN SUPEROXIDE DISMUTASER01GM054903 · NIGMS · UNIVERSITY OF FLORIDA · PI SILVERMAN, DAVID N · 1996 to 2004
$1.0M
NIGMS NIH HHS GM54903NIGMS NIH HHS R01 GM054903
6 · The paper itself

Abstract

Superoxide dismutase (SOD) enzymes are critical in controlling levels of reactive oxygen species (ROS) that are linked to aging, cancer, and neurodegenerative disease. Superoxide (O(2)(*-)) produced during respiration is removed by the product of the SOD2 gene, the homotetrameric manganese superoxide dismutase (MnSOD). Here, we examine the structural and catalytic roles of the highly conserved active-site residue Tyr34, based upon structure-function studies of MnSOD enzymes with mutations at this site. Substitution of Tyr34 with five different amino acids retained the active-site protein structure and assembly but caused a substantial decrease in the catalytic rate constant for the reduction of superoxide. The rate constant for formation of the product inhibition complex also decreases but to a much lesser extent, resulting in a net increase in the level of product inhibited form of the mutant enzymes. Comparisons of crystal structures and catalytic rates also suggest that one mutation, Y34V, interrupts the hydrogen-bonded network, which is associated with a rapid dissociation of the product-inhibited complex. Notably, with three of the Tyr34 mutants, we also observe an intermediate in catalysis, which has not been reported previously. Thus, these mutants establish a means of trapping a catalytic intermediate that promises to help elucidate the mechanism of catalysis.

Indexed as

CatalysisCatalytic DomainConserved SequenceCrystallography, X-RayDNA Mutational AnalysisHumansKineticsManganeseOxidation-ReductionStructure-Activity RelationshipSuperoxide DismutaseSuperoxide Dismutase 2SuperoxidesTyrosineManganeseSuperoxide DismutaseSuperoxide Dismutase 2SuperoxidesTyrosine

Identifiers

PMID19265433
PMCPMC2756076
OpenAlexW2095450601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.